MedPath

Comparative study of 2 different doses of magnesium sulfate treatment as a drug to prevent fits in patients of eclampsia .

Not Applicable
Conditions
Health Condition 1: O159- Eclampsia, unspecified as to timeperiod
Registration Number
CTRI/2022/08/045003
Lead Sponsor
Dr Smrity Naik
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients of Eclampsia admitted in our hospital during the study period.

Exclusion Criteria

Patients of Eclampsia with additional pathology such as renal disease or renal failure , encephalopathy, chronic liver disease , chronic lung disease and Eclampsia patients who have received any other anticonvulsant other than magnesium sulfate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath